The cellular, immune, and metabolic response to trauma

Critical Reviews in Clinical Laboratory Sciences

Volumn 35, Issue 1, 1998, Pages 59-112

  Gosling, Peter ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; FREE RADICAL; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL FUNCTION; CAPILLARY PERMEABILITY; CARDIOVASCULAR SYSTEM; CELL ACTIVITY; CELL DAMAGE; CELL FUNCTION; CELL HYPOXIA; CELL INTERACTION; CELL MEMBRANE; FLUID BALANCE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HYPOPHYSIS FUNCTION; IMMUNE RESPONSE; INJURY; KIDNEY FUNCTION; LIVER FUNCTION; LUNG FUNCTION; LYMPHOCYTE FUNCTION; MALE; METABOLISM; MITOCHONDRION; MULTIPLE TRAUMA; NEUTROPHIL; NUTRIENT; PANCREAS FUNCTION; PRIORITY JOURNAL; REVIEW; SHOCK; THYROID FUNCTION; VASCULAR ENDOTHELIUM;

ANIMALS; AUTOCRINE COMMUNICATION; CAPILLARY PERMEABILITY; CELL HYPOXIA; FREE RADICALS; HUMANS; INFLAMMATION; MULTIPLE TRAUMA; NEUTROPHIL ACTIVATION; PARACRINE COMMUNICATION;

EID: 0031967076     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Cuthbertson DP. The disturbance of metabolism produced by bony and non-bony injury with notes on certain abnormal conditions of bone. Biochem J 1930; 24: 1244-63.
2. Goris RJA. A unified theory of multiple organ failure: generalised inflammation. In: Zikria BA, Ox MO, Carlson RW, eds. Reperfusion injuries and clinical capillary leak syndrome. Pp. 411-42. Armonk, NY: Futura Publishing Company, 1994.
3. Baue AE. Physiology of shock and injury. In: Geller E, ed. Shock and resuscitation. Pp. 67-126. New York: McGraw-Hill, Health Professions Division, 1993.
4. Hardaway RM. Theories of shock. In: Hardaway RM, ed. Shock: the reversible stage of dying. Pp. 11-25. Littleton, Massachusetts: PSG Publishing, 1988.
5. Hardaway RM. Definitions of shock. In: Hardaway RM, ed. Shock: the reversible stage of dying. Pp. 1-3. Littleton, Massachusetts: PSG Publishing, 1988.
6. Simone FA. Wound shock. In: Bowers WF, ed. Surgery of trauma. Pp. 25-30. Philadelphia : JB Lippincott Co, 1953.
7. Zikria BA, Bascom JU. Mechanisms of multiple system organ failure. In: Zikria BA, Oz MO, Carlson RW, eds. Reperfusion injuries and clinical capillary leak syndrome. Pp. 443-92. Armonk NY: Futura Publishing Company, 1994.
8. Gosling P, Marshall WJ Clapham MC. Definition of shock. In: Intensive care and clinical biochemistry. Pp. 2-3. Association of Clinical Biochemists London: Venture Publications, 1994.
9. Drucker WR, Chadwick CDJ Gann DS. Transcapillary refill in hemorrhage and shock. Arch Surg 1981; 116: 134-53.
10. Schmidt FW, Schmidt E, Ohlendorf S et al. Assay of mitochondrial aspartate transaminase (m-AST) by immunoprecipitation and column chromatography in sera of patients with liver disease. Sel Topics Clin Enzymol 1984; 2: 205-16.
11. Huckabee WE. Abnormal resting blood lactate. I. The significance of hyperlacticemia in hospitalised patients. Am J Med 1961; 30: 833-39.
12. Broder G, Weil MH. Excess lactate: index of reversibility of shock in human patients. Science 1964; 143: 1457-59.
13. Luft D, Deichsel G, Schmulling RM, et al. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Path 1983; 80: 484-9.
14. Abramson D, Scalea T, Hitchcock R, et al. Lactate clearance and survival following injury. J Trauma 1993; 35: 588-9.
15. Mikulaschek A, Henry SM, Donovan R, et al. Serum lactate is not predicted by anion gap or base excess after trauma resuscitation. J Trauma 1996; 40: 218-223.
16. Ozawa K, Aoyama H, Yasuda K, et al. Metabolic abnormalities associated with post-operative organ failure. A redox theory. Arch Surg 1983; 118: 1245-51.
17. Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 1995; 369: 136-9.
18. Richter C, Godvadze V, Laffranchi R, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995; 1271: 67-74.
19. Shires GT, Cunningham JN, Backer CR, et al. Alterations in cellular membrane function following hemorrhagic shock in primates. Ann Surg 1972; 176: 288-95.
20. Schanne FA, Kane AB, Young EE, et al. Calcium dependence of toxic cell death: a final common pathway. Science 1979; 206: 700-2.
21. Farber JL. The role of calcium in cell death. Life Sci 1981; 29: 1289-95.
22. Feola M, Simoni J, Tran R, Lox CD, et al. Toxic factors in the red blood cell membrane. J Trauma 1989; 29: 1065-75.
23. Lunec J. Free radicals: their involvement in disease processes. Ann Clin Biochem 1990; 27: 173-82.
24. Ward RJ, Peters TJ. Free radicals. In: Marshall WJ, Banghert SK, eds. Clinical biochemistry: metabolic and clinical aspects. Pp. 765-77. London: Churchill Livingstone, 1995.
25. Young S, Beswick P. A comparison of the oxidative reactions of neutrophils from a variety of species when stimulated by opsonized zymosan and FMLP. J Comp Pathol 1986; 96: 189-96.
26. Roumen RMH, Hendriks T, de Man BM, et al. Serum lipofuscin as a prognostic indicators of adult respiratory distress syndrome and multiple organ failure. Br J Surg 1994; 81: 1300-5.
27. Girotti MJ, Khan N McLellan BA. Early measurements of systemic lipid peroxidation products in the plasma of major blunt trauma patients. J Trauma 1991; 31: 32-5.
28. Gosling P, Sutcliffe AJ, Cooper ACS, et al. Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann Clin Biochem 1988; 25: 53-9.
29. Shearman CP, Gosling P, Gwynn BR, et al. Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease? Eur J Vasc Surg 1988; 2: 401-4.
30. Khaira HS, Nash GB, Bahra PS, et al. Thromboxane and neutrophil changes following intermittent claudication suggests ischaemia-reperfusion injury. Eur J Vasc Surg 1995; 10: 31-5.
31. Friese RS, Rehring TF, Wollmering M, et al. Trauma primes cells. Shock 1994; 1: 388-94.
32. ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
33. Palmer RMJ, Ferrige AG Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
34. Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isoenzymes: characterisation, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-31.
35. Leone AM, Palmer RMU, Knowles RG et al. Constitutive and inducible nitric oxide synthases incorporate molecular oxygen in both nitric oxide and citrulline. J. Biol Chem, 1991; 226: 23790-5.
36. Moncada S, Palmer RMJ Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
37. Vallance P, Monacada S. The role of nitric oxide in septic shock. New Horizons 1993; 1: 77-86.
38. Rixen D, Siegel JH, Espina N, et al. Plasma nitric oxide in posttrauma critical illness: a function of 'sepsis' and the physiologic state severity classification quantifying the probability of death. Shock 1997; 1: 17-28.
39. Preiser JC, Reper P, Vlasselaer D, et al. Nitric oxide production is increased in patients after burn injury. J Trauma 1996; 40: 368-71.
40. Jacob TD, Ochoa JB, Udekwu AO, et al. Nitric oxide production is inhibited in trauma patients. J Trauma 1993; 35: 590-6.
41. Ochoa JB, Udekwu AO, Billar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-6.
42. Petty R, Pearson JD. Endothelium - the axis of vascular health and disease. J Royal College of Physicians of London 1989; 23: 92-102.
43. Szabo C, Thiemermann C. Invited opinion: the role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and thermal injury. Shock 1994; 2: 145-55.
44. Gerlach H, Rossaint R, Pappert D, et al. Time course and dose response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502.
45. Greenough A. Nitric oxide - clinical aspects. Care of the Critically Ill 1995; 11: 143-6.
46. Fujishima S, Aikawa N. Neutrophjil-mediated tissue injury and its modulation. Intensive Care Medicine 1995; 21: 277-85.
47. Cioffi WG, Burleson DG Pruitt BA. Leukocyte responses to injury. Arch Surg 1993; 128: 1260-7.
48. Kulkarni V, Webster N. Management of sepsis. Care of the Critically Ill 1996; 12: 122-7.
49. Smith CW. Leukocyte-endothelial cell interactions. Semi Hematol 1993; 30 S4: 45-55.
50. Boldt J, Wollbruch M, Kuhn D, et al. Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 1995; 107: 787-92.
51. Petty TL. Adult respiratory syndrome: definition and historical perspective. Clin Chest Med 1982; 3: 3-7.
52. Tonz M, Mihaljevic T, von Segesser LK, et al. Acute lung injury during cardiopulmonary bypass: are the neutrophils responsible? Chest 1995; 108: 1551-6.
53. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-7.
54. Fujishima S, Sasaki J, Shinozawa Y, et al. Interleukin 8 in ARDS. Lancet 1993; 342: 237-8.
55. Fisher CJ, Dhainaut JF, Pribble JP, et al. The IL-ra Phase III Sepsis Syndrome Study Group. A phase II multicenter trial of human recombinant interleukin-1 receptor antagonist (IL-1ra) in the treatment of patients with sepsis syndrome. Lymphokine Cytokine Res. 1993; 12: 390.
56. Marzi I, Buhren V, Schuttler A, et al. Value of Superoxide dismutase for prevention of multiple organ failure after multiple trauma. J Trauma 1993; 35: 110-20.
57. Zhu N, Liggit D, Lui Y, et al. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-11.
58. Hershman MJ, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77: 204-7.
59. Calvano SE, Barber AE, Hawes AS, et al. Effect of combined cortisol endotoxin administration on peripheral blood leucocyte counts and phenotype in normal humans. Arch Surg 1992; 127: 181-6.
60. Lucey DR, Clerici M Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev 1996; 9: 532-62.
61. Dries JR, Jurkovich GJ, Maier RV, et al. Effect of interferon gamma on infection-related deaths in patients with severe injuries: a randomized double-blind placebo-controlled trial. Arch Surg 1994; 129: 1031-41.
62. Guillou PJ. Adjuvant biological response modifiers after major surgery or trauma. Br J Surg 1995; 82: 721-3.
63. Welsh FK, Farmery SM; Ramsdent C, et al. Reversible impairment in monocyte major histocompatibility complex class II expression in malnourished patients. J Parenter Enteral Nutr 1996; 20: 344-8.
64. Crum R, Bobrow B, Shackford S, et al. The neurohormonal response to burn injury in patients resuscitated with hypertonic saline. J Trauma 1988; 28: 1181-7.
65. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985; I: 781-4.
66. Klein N, Shennan G, Heyderman R, et al. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci. 1992; 102: 821-32.
67. Kanwar YS. Biophysiology of glomerular filtration and proteinuria. Lab Invest 1984; 51: 7-21.
68. Taylor AE, Moore T Khimenko P. Microcirculatory exchange of fluid and protein and development of the third space. In: Zikria BA, Oz MO, Carlson RW, eds. Reperfusion injuries and clinical capillary leak syndrome. Pp. 59-92. Armonk, New York: Futura Publishing Company 1994.
69. Gosling P, Bascom JU Zikria BA. Capillary leak, edema and organ failure: breaking the triad. Care of the Critically Ill 1996; 12: 191-7.
70. Nuytinck HKS, Offermans XJMW, Kubat K, et al. Whole body inflammation in trauma patients, an autopsy study. In: First Vienna Shock Forum, Part A: Pathophysiological role of mediators and mediator inhibitors in shock. Pp. 55-61. New York: Alan R Liss Inc., 1987.
71. Gosling P. Microalbuminuria: a marker of systemic disease. Br J Hosp Med 1995; 54: 285-290.
72. Zikria BA, Bascom JU. Mechanisms of multiple organ failure. In: Zikria BA, Oz MO, Carlson, eds. Reperfusion injuries and clinical capillary leak syndrome. Pp. 443-92. Armonk, New York, Futura Publishing Company, 1994.
73. Gosling P, Shearman CP, Gwynn BR, et al. Microproteinuria: response to operation. Br Med J 1988; 296: 3338-9.
74. Gosling P, Hughes EA, Reynolds TM, et al. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991; 12: 508-13.
75. Smith CT, Gosling P, Sanghera K, et al. Microproteinuria predicts the severity of systemic effects of reperfusion injury following infra renal aortic aneurysm surgery. Ann Vasc Surg 1994; 8: 1-5.
76. Pallister I, Gosling P, Alpar K, et al. Prediction of post-traumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. J Trauma 1997; 42: 1056-61.
77. Gosling P, Sanghera K Dickson G. Generalized vascular permeability and pulmonary function in patients following serious trauma. J Trauma 1994; 36: 1-5.
78. Zikria BA, King TC, Stanford J, et al. A biophysical approach to capillary permeability. Surgery 1989; 105: 625-31.
79. Trauber LD, Brazeal BA Scmitz M. Pentafraction reduces the lung lymph response after endotoxin administration in the ovine model. Circ Shock 1992; 36: 93-7.
80. Yeh T Jr, Pamar JM Reseyka IM. Limiting edema in neonatal cardiopulmonary bypass with narrow range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 1992; 14: 659-63.
81. Webb AR, Tigh D, Moss RF, et al. Advantages of narrow-range medium molecular weight hydroxyethyl starch for volume maintenance in porcine model of fecal peritonitis. Crit Care Med 1991; 19: 409-16.
82. Van den Burgh GH, De Zegher FE. A senescent pattern of pituitary function during critical illness and dopamine treatment. Verh K Geneeskd Belg 1996; 58: 383-411.
83. Barrett M. Renal function following thermal injury. Care of the Critically Ill 1986; 2: 197-201.
84. Barton R. Effect of limb ischemia and scalding on the concentrations of growth hormone and corticosterone in rat plasma. J Endocrin 1977; 73: 347-53.
85. Carey LC, Cloutier CT Lavery BD. Growth hormone and adrenal cortical response to shock and trauma in the human. Ann Surg 1971; 174: 451-60.
86. Melarvie S, Jeevanandam M, Holaday NJ, et al. Pulsatile nature of growth hormone levels in critically ill trauma victims. Surgery 1995; 117: 402-8.
87. Van Den Burgh G, De Zegher F, Lauwers P, et al. Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrin Metab 1994; 79: 1141-6.
88. Aun F, Medeiros-Neto GA, Younes RN, et al. The effect of major trauma on the pathways of thyroid hormone metabolism. J Trauma 1983; 23: 1048-51.
89. Murav'ev OB, Maiorova EM Volkov AV. Characteristics of changes in the thyroid status in severe trauma and massive hemorrhage. Anesteziologiia i Reanimaologiia. 1994; 14-17.
90. Becker RA, Wilmore DW, Goodwin LW, et al. Free T4, free T3 and reverse T3 in critically ill, thermally injured patients. J Trauma 1980; 20: 713-21.
91. Rothwell PM, Udwadia ZF Lawler PG. Thyrotropin concentrations predicts outcome in critical illness. Anaesthesia 1993; 48: 373-76.
92. Van Den Bergh G, De Zegher F, Bowers CY et al. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Clin Endocrinol (Oxford) 1996; 45: 341-51.
93. Bessey PQ, Brooks DC Black PR. Epinephrine acutely mediates skeletal muscle insulin resistance. Surgery 1983; 94: 172-9.
94. Little RA, Stoner HB Frayn KN. Substrate oxidation shortly after accidental injury in man. Clin Sci 1981; 61: 789-91.
95. Frayn KN. Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol (Oxford) 1986; 24: 577-99.
96. Unger RH. Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes 1971; 20: 834-8.
97. Byron K, Botting K Wooton A. Cytokines: new markers of inflammation? Clin Biochm Rev 1995; 16: 38-44.
98. Meade P, Shoemaker WC, Donnelly TJ. Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma 1994; 651-57.
99. Rocker GM, Wiseman JS, Pearson D, et al. Neutrophil degranulation and increased pulmonary capillary permeability following oesophagectomy: a model of early lung injury in man. Br J Surg 1988; 75: 883-5.
100. Frostell CG. Lung permeability and other pathophysiological lung problems in shock. Acta Anesthesiol Scand 1993; 37 Supp 98: 11-3.
101. Gamelli RL, Silver GM. Acute renal failure. In: Deitch E, ed. Multiple organ failure. Pp. 216-40. New York: Theime Medical Publishers, 1990.
102. Molnar ZL, Shearer ES. Rhabdomyolysis on the intensive care unit - an under-diagnosed condition. Care of the Critically Ill 1996; 12: 165-68.
103. Crook M, Swaminathan R. Disorders of plasma phosphate and indications for its measurement. Ann Clin Biochem 1996; 33: 376-96.
104. Feliciano DV, Jordan CG, Jr, Burch JM, et al. Management of 1000 consecutive cases of hepatic trauma. (1979-1984). Ann Surg 1986; 204: 438-45.
105. Fleck A, Colley CM Myers MA. Liver export proteins and trauma. Br Med Bull 1985; 41: 265-73.
106. Whicher JT, Dieppe PA. Acute phase proteins. Clin Immunol Allergy 1985; 5: 425-30.
107. Gosling P, Dickson GR. Serum C-reactive protein in patients with serious trauma. Injury 1992; 23: 483-6.
108. De Bandt JP, Chollet-Martin S, Hernvann A, et al. Cytokine response to burn injury: relationship with protein metabolism. J Trauma 1994; 36: 624-29.
109. Lafargue P, Couture JC, Monteil R, et al. Evolution des concentrations seriques du cuirve et du zinc chez le brule. Clin Chim Acta 1976; 66: 181-8.
110. Shakespeare PG. Studies on the serum levels of iron, copper and zinc and the urinary excretion of zinc after burn injury. Burns 1982; 8: 358-62.
111. Shewmake KB, Talbert GE, Bowser-Wallace BH, et al. Alterations in plasma copper, zinc and ceruloplasmin levels in patients with thermal trauma. J Burn Care Rehabil 1988; 9: 13-7.
112. Berger MM, Cavadini C, Bart A, et al. Cutaneous copper and zinc losses in burns. Burns 1992; 18: 373-80.
113. Brian JE, Caldwell FT, Woody RC, et al. Hypocuprinemia in a major burn. J Trauma 1987; 27: 335-6.
114. Gosling P, Sheehan TM, Rothe HM. Serum zinc and copper concentrations in patients following burn injury and trauma. Proceedings of the Association of Clinical Biochemists Meeting 1992; p. 74.
115. Gosling P, Rothe HM, Sheehan TNT, et al. Serum copper and zinc concentrations in patients with burns in relation to burn surface area. J Burn Care Rehabil 1995; 16: 481-6.
116. Fell GS, Fleck A, Cuthbertson DP, et al. Urinary zinc levels as an indication of muscle catabolism. Lancet 1973; 1: 280-282.
117. Myers MA, Fleck A, Sampson B, et al. Early plasma protein and mineral changes after surgery: a two-stage process. J Clin Path 1984; 37: 862-6.
118. Shanhogue LK, Paterson N. Effect of sepsis and surgery on trace minerals. J Enteral Parent Nutr 1990; 14: 287-9.
119. Coyle P, Philcox C Rofe A. Clinical significance of metallothionein: a dealer in heavy metals. Clin Biochem Rev 1993; 14: 118-25.
120. Chesters JK, Will M. Measurement of zinc flux through plasma in normal and endotoxin-stressed pigs and the effects of zinc supplementation during stress. Br J Nutr 1981; 46: 111-118.
121. Golden MHN. The diagnosis of zinc deficiency. In: Mills CF, ed. Zinc in human biology. Berlin: Springer Verlag, 1989.
122. Cousins RJ. Adsorption, transport and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplsmin. Physiol Rev 1985; 65: 239-309.
123. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple-organ-failure syndrome. Arch Surg 1986; 121: 196-208.
124. Fiddian-Green RG. Splanchnic ischaemia and multiple organ failure in the critically ill. Annals of the Royal College of Surgeons of England 1988; 70: 128-34.
125. Solverman HJ. Gastric tonometry: an index of splanchnic oxygenation? Crit Care Med 1991; 19: 1223-4.
126. Walsh DS, Thavichaigarn P, Dheeradhada C, et al. Prolonged alteration in gut permeability following nonthermal injury. Injury 1996; 27: 491-4.
127. Roumen R, Hendriks T, Wevers RA, et al. Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 1993; 128: 453-7.
128. Pape HC, Dwenger A, Regel G, et al. Increased gut permeability after multiple trauma. Br J Surg 1994; 81: 850-2.
129. Langkamp-Henken B, Donovan T, Pate L, et al. Increased intestinal permeability following blunt trauma and penetrating trauma. Crit Care Med 1995; 23: 660-4.
130. Deitch EA. Gut failure: its role in multiple organ failure syndrome. In: Deitch EA, ed. Multiple organ failure. Pp. 40-59. New York: Theime Medical Publishers Inc., 1990; 40-59.
131. Wardle EN. Prevention and treatment of septic shock, SIRS, ARDS and multi-organ failure. I. Care of the Critically Ill 1996; 12: 177-80.
132. 2 in immune suppression following injury. Ann Surg 1991; 214: 253-63.
133. Miller-Graziano CL, Szabo G, Griffey K, et al. Role of elevated monocyte transforming factor beta production in post-traumatic immunosuppression. J Clin Immunol 1991; 11: 95-102.